Shortsell.net [Beta]

Nanobiotix

NBTX

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts.

Nanobiotix has been a target of short sellers for a while. The current short interest of 0.34% is roughly at the average of the last 12 months (0.15%).

Short Interest Trend
Total NSP
0.34%
+0.05%
vs. last month
This company is additionally tracked by the other data source (US short interest vs. European/Norwegian filings). The figures are different metrics and cannot be added. Open the other entry (1.09%)